|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 October 2017 |
|
Main ID: |
NCT01138969 |
|
Date of registration:
|
07/06/2010 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer
|
|
Scientific title:
|
Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer and Gastrointestinal Bleeding |
|
Date of first enrolment:
|
August 2008 |
|
Target sample size:
|
165 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT01138969 |
|
Study type:
|
Interventional |
|
Study design:
|
|
|
Phase:
|
Phase 2
|
|
|
Countries of recruitment
|
|
Taiwan
| | | | | | | |
|
Contacts
|
|
Name:
|
Kwok-Hung Lai, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Kaohsiung Veterans General Hospital. |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- We plan to enroll 300 clopidogrel users without baseline gastroduodenal ulcer at
initial endoscopy. The patients will be randomly assigned to receive either (1)
esomeprazole (20 mg qd) plus clopidogrel or (2) clopidogrel treatment alone for 6
months.
Exclusion Criteria:
- 1.serious disease 2.refuse informed consent
Age minimum:
N/A
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Peptic Ulcer
|
|
Intervention(s)
|
|
Drug: esomeprazole
|
|
Primary Outcome(s)
|
|
Recurrent Peptic Ulcer
[Time Frame: 6 months]
|
|
Secondary Outcome(s)
|
|
Peptic Ulcer Bleeding
[Time Frame: 6 months]
|
|
Secondary ID(s)
|
|
VGHKS98-CT6-12
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|